D.C. Mun. Regs. tit. 22, r. 22-A6346
MAT is the combination of FDA approved medication with behavioral therapies to treat SUD. A client who receives medication to treat SUD must also receive SUD Counseling/Therapy. Use of this service should be in accordance with ASAM criteria and practice guidelines issued by the Department.
Clients appropriate for MAT must have an SUD that could be appropriately treated in accordance with Federal regulations.
OTPs must ensure that individuals receiving MAT understand and provide written informed consent to the specific medication administered. No client under age eighteen (18) may be admitted to an OTP unless a parent or legal guardian consents in writing to such treatment.
MAT may be administered on an in-office basis or as take- home regimen. Both MAT administrations include the unit of medication and therapeutic guidance. For clients receiving a take-home regimen, therapeutic guidance must include additional guidance related to storage and self-administration. OTPs must comply with all Federal and District laws and regulations concerning MAT.
Therapeutic guidance provided during MAT shall include:
The provision of MAT must be accompanied by a clinically appropriate array of SUD treatment services in accordance with §6330 that include SUD Counseling/Therapy.
A physician must evaluate the client a minimum of once per month for the first year that a client receives MAT and a minimum of every six (6) months thereafter, in coordination with the Plan of Care and as needed.
Documentation for this service must include medication log updates and an encounter note for each visit, which captures the therapeutic guidance provided.
Qualified Practitioners of MAT are:
D.C. Mun. Regs. tit. 22, r. 22-A6346